The Spectrum of Allergic Rhinitis: Risk Factors and their Clinical Relevance
Allergic rhinitis (AR) is a common, chronic inflammatory disorder of the upper respiratory tract, primarily caused by exposure to environmental allergens such as pollen, dust mites, and mold. It has a substantial impact on daily life, often leading to sleep disruption, decreased productivity, and a heightened risk of asthma and other related conditions. The underlying mechanism of AR involves an IgE-mediated immune reaction, with both immediate and delayed inflammatory responses contributing to ongoing symptoms. AR can be classified into several types-seasonal, perennial, occupational, and drug-induced-which aids in its diagnosis and personalized management. Key risk factors include hereditary susceptibility, environmental pollution, and modern lifestyle factors. Diagnosis is typically based on a detailed medical history, skin prick testing, and serum IgE measurements. Treatment strategies involve the use of antihistamines, intranasal corticosteroids, and leukotriene receptor antagonists, complemented by allergen-specific immunotherapy and lifestyle modifications such as allergen avoidance. In recent years, advanced therapies like targeted biologics (e.g., dupilumab) and probiotic-based treatments have emerged, offering promising new avenues for patients with persistent or severe symptoms.
Authors
- Bhavani Pentela (ORCID: https://orcid.org/0000-0002-4130-070X)
- Priyanka Bansal (ORCID: https://orcid.org/0009-0008-2945-5427)
- Hari Niwas
Institutions
- Jaypee Institute of Information Technology (IN)
Publication Details
- Journal
- Recent Advances in Inflammation & Allergy Drug Discovery
- Published
- 2025-10-21
- DOI
- https://doi.org/10.2174/0127722708397912251001102439
- Primary Topic
- Allergic Rhinitis and Sensitization
- Type
- article
- Field-Weighted Citation Impact
- 0.00